Literature DB >> 10454948

Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting.

M A Montecalvo1, W R Jarvis, J Uman, D K Shay, C Petrullo, K Rodney, C Gedris, H W Horowitz, G P Wormser.   

Abstract

BACKGROUND: Vancomycin-resistant enterococci (VRE) are nosocomial pathogens in many U. S. hospitals.
OBJECTIVE: To determine whether enhanced infection-control strategies reduce transmission of VRE in an endemic setting.
DESIGN: Prospective cohort study.
SETTING: Adult oncology inpatient unit. PATIENTS: 259 patients evaluated during use of enhanced infection-control strategies and 184 patients evaluated during use of standard infection-control practices.
INTERVENTIONS: Patient surveillance cultures were taken, patients were assigned to geographic cohorts, nurses were assigned to patient cohorts, gowns and gloves were worn on room entry, compliance with infection-control procedures was monitored, patients were educated about VRE transmission, patients taking antimicrobial agents were evaluated by an infectious disease specialist, and environmental surveillance was performed. MEASUREMENTS: VRE infection rates, VRE colonization rates, and changes in antimicrobial use.
RESULTS: During use of enhanced infection-control strategies, incidence of VRE bloodstream infections decreased significantly (0.45 patients per 1000 patient-days compared with 2.1 patients per 1000 patient-days; relative rate ratio, 0.22 [95% CI, 0.05 to 0.92]; P = 0.04), as did VRE colonization (10.3 patients per 1000 patient-days compared with 20.7 patients per 1000 patient-days; relative rate ratio, 0.5 [CI, 0.33 to 0.75]; P < 0.001). Use of all antimicrobial agents except clindamycin and amikacin was significantly reduced.
CONCLUSION: Enhanced infection-control strategies reduced VRE transmission in an oncology unit in which VRE were endemic.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10454948     DOI: 10.7326/0003-4819-131-4-199908170-00006

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  28 in total

Review 1.  What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals?

Authors:  Ben Ridwan; Ellen Mascini; Netty van Der Reijden; Jan Verhoef; Marc Bonten
Journal:  BMJ       Date:  2002-03-16

Review 2.  Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci.

Authors:  Stephan Harbarth; Sara Cosgrove; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

3.  Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage.

Authors:  James A McKinnell; Danielle F Kunz; Eric Chamot; Mukesh Patel; Rhett M Shirley; Stephen A Moser; John W Baddley; Peter G Pappas; Loren G Miller
Journal:  Infect Control Hosp Epidemiol       Date:  2012-05-14       Impact factor: 3.254

4.  Effective cohorting and "superisolation" in a single intensive care unit in response to an outbreak of diverse multi-drug-resistant organisms.

Authors:  Laura H Rosenberger; Tjasa Hranjec; Amani D Politano; Brian R Swenson; Rosemarie Metzger; Hugo Bonatti; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2011-09-21       Impact factor: 2.150

5.  Nosocomial or Healthcare Facility-Related Pneumonia in Adults.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

6.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

7.  Vancomycin-resistant enterococci in Canada revisited.

Authors:  B L Johnston; J M Conly
Journal:  Can J Infect Dis       Date:  2000-05

Review 8.  Hospital infection control strategies for vancomycin-resistant Enterococcus, methicillin-resistant Staphylococcus aureus and Clostridium difficile.

Authors:  B Lynn Johnston; Elizabeth Bryce
Journal:  CMAJ       Date:  2009-03-17       Impact factor: 8.262

9.  Rapid curbing of a vancomycin-resistant Enterococcus faecium outbreak in a nephrology department.

Authors:  Aude Servais; Lucile Mercadal; Florence Brossier; Marcia Venditto; Belkacem Issad; Corinne Isnard-Bagnis; Gilbert Deray; Jérôme Robert
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 8.237

10.  Antibiotic resistance patterns of bacterial isolates from blood in San Francisco County, California, 1996-1999.

Authors:  Susan S Huang; Brian J Labus; Michael C Samuel; Dairian T Wan; Arthur L Reingold
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.